Powerful antioxidant that fights free radicals, detoxifies the body and boosts immune
Dextrose infusions are administered to provide calories and limit ketosis
Regulatory approvals, such as semaglutide (Wegovy) for obesity management in addition to diabetes treatment, have expanded the eligible patient population, thereby accelerating market adoption
Although Ozempic is not explicitly approved for chronic weight management, it can be prescribed off-label and used safely for people who are obese
What the clinical trial evidence shows Mounjaro (tirzepatide) ~22.5% average body weight lost at 72 weeks ( SURMOUNT-1, 15mg) Wegovy (semaglutide) ~14.9% average body weight lost at 68 weeks ( STEP-1 , 2.4mg) Saxenda / Nevolat (liraglutide) ~5-8% average body weight lost at 56 weeks ( SCALE trial ) For context, prior to GLP-1 medications, the most effective non-surgical weight loss intervention available was a combination of intensive lifestyle modification and Orlistat , which typically produces 5 to 8% weight loss
You would need life-threatening complications from your weight, like severe heart failure or the inability to breathe properly
.jpg)
